Pure Global
NCT06386679

Amniotic Fluid Mesenchymal Stem Cells Developed for Chondrogenic Treatment (AFCC) Injection in Elderly Knee Osteoarthritis Patients

A Pilot Study: Safety and Efficacy of Allogenic Mesenchymal Stem Cell Type AFCC for Treating in Elderly Knee Osteoarthritis Patients
Siriraj Hospital·Phase 1·ClinicalTrials.gov·biologicalEnrolling by invitation
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Knee Osteoarthritis
Drug/Device/Intervention
allogenic amniotic fluid mesenchymal stem cell
Study type
Interventional
Intervention type
biological
Sponsor & location
Primary sponsor
Siriraj Hospital
Location
Bangkok Noi, Thailand
Timeline & enrollment
Phase
Phase 1
Start date
Aug 17, 2023
End date
Mar 01, 2025
Enrollment
10 participants
Primary outcome

Incidence of abnormal physical examination,Incidence of abnormal vital sign,Incidence of abnormal laboratory test results,Incidence of abnormal ECG parameters,The type of Adverse event (AE), numbers of AE and proportion of patients with AE.

Summary

Amniotic fluid mesenchymal stem cells developed for chondrogenic treatment (AFCC) are used to
 treat elderly patients suffering from knee osteoarthritis (OA). The injection reduces
 inflammation and promotes the recovery of knee function, leading to an improved quality of
 life.

ICD-10 classifications
Chronic instability of kneeGonarthrosis [arthrosis of knee]Other hypertrophic osteoarthropathyDislocation, sprain and strain of joints and ligaments of kneePatellofemoral disorders
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06386679
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06386679 through Pure Global AI's free database. This Phase 1 trial is sponsored by Siriraj Hospital and is currently Enrolling by invitation. The study focuses on Knee Osteoarthritis. Target enrollment is 10 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.